N04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
|The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.|
No separate DDDs are established for oral depot formulations.
N04B DOPAMINERGIC AGENTS
N04BB Adamantane derivatives
Last updated: 2016-12-19